Duavee

Short answer Start by asking your clinician for FDA‑approved hormone therapy — ideally bioidentical estradiol and (if you have a uterus) micronized progesterone — rather than unregulated compounded BHRT. If standard options don’t control symptoms or you have special needs, consider compounded “BHRT” only after careful discussion and using a reputable compounding pharmacy. What “BHRT” vs “traditional HRT” means (quick) “Traditional” HRT usually refers to FDA‑approved estrogen and progestin products. Some are bioidentical molecules (estradiol, micronized progesterone); others are synthetic progestins (medroxyprogesterone). “BHRT” is a marketing term that can mean either FDA‑approved bioidentical hormones (same chemical structure as human hormones) or custom‑made, non‑FDA‑tested preparations from compounding pharmacies. The latter are what people usually mean by “compounded BHRT.” Why I recommend FDA‑approved bioidentical options first Consistent potency, manufacturing standards, labeled dosing, and safety data (FDA oversight). Easier to monitor and adjust safely. Some FDA‑approved products are bioidentical (same chemical structure) — you can get the “bioidentical” hormones without the downsides of compounding. Specific FDA‑approved brands/services to ask about (examples) Estradiol (estrogen) Transdermal patches: Vivelle‑Dot, Climara — transdermal route lowers blood clot risk vs oral in many people. Oral estradiol: Estrace (estradiol tablets). Transdermal gel/spray: EstroGel, Evamist (if you prefer non‑patch topical). Progesterone (if you have a uterus) Prometrium (micronized progesterone) — a bioidentical progesterone with FDA data (different risk profile than synthetic progestins). Combination bioidentical product Bijuva (oral combined estradiol + progesterone) — FDA‑approved combined bioidentical product for menopausal symptoms. Alternatives for women who can’t take estrogen Duavee (conjugated estrogen + bazedoxifene) for some postmenopausal women (bone/vasomotor symptoms) — not appropriate if you still have a uterus and need progestin in the usual way; discuss with clinician. Compounded BHRT (caution) Compounded creams, troches, or custom mixes may be useful in specific situations (allergies to components, unusual dosing), but: They are not FDA‑approved, have variable potency and consistency, and lack long‑term safety data. If you pursue compounding, use a high‑quality, accredited compounding pharmacy (check USP <795>/<797> compliance and pharmacist/physician references) and insist on certificate of analysis and clear monitoring plan. Where to get care Primary routes: Your OB‑GYN or primary care doctor (start here if you have an ongoing provider). A menopause specialist (board‑certified gynecologist or internist with menopause expertise). Use the North American Menopause Society (NAMS) provider directory or major centers (Mayo Clinic, Cleveland Clinic) if you need a specialist. Reputable telemedicine services specializing in menopause/HRT (e.g., BodyLogicMD, Ever/Modern Menopause clinics, or large telemedicine platforms that connect to OB‑GYNs). Confirm they prescribe FDA‑approved products and provide follow‑up and monitoring. Compounding pharmacies (if used) — examples known in the field include Wedgewood Pharmacy and other nationally used compounding labs, but vet any pharmacy carefully. Avoid services that promise “natural” cures without discussion of risks/monitoring or that recommend testing panels (saliva hormone panels) that aren’t clinically useful for treatment decisions. What to ask your clinician (script) “Which hormone options do you recommend for my symptoms and medical history?” “Can we use FDA‑approved estradiol and micronized progesterone (or Bijuva) instead of compounded hormones?” “Given my age, smoking, clotting history, breast cancer risk, and cardiovascular risk, what route and dose are safest?” “How will we monitor symptoms and side effects? What baseline tests do you recommend (mammogram, blood pressure, lipids, etc.) and how often?” “If standard options don’t work, what are the pros and cons of compounded BHRT for me?” Safety and monitoring — key points HRT reduces vasomotor symptoms and can improve quality of life. Risks (breast cancer, VTE, stroke, heart disease) depend on age, time since menopause, dose, and formulation. Generally safer if started before age ~60 or within 10 years of menopause onset. Transdermal estradiol may carry lower VTE risk than oral estradiol. Use the lowest effective dose and reassess regularly (6–12 weeks initially, then every 6–12 months). Baseline and routine monitoring: blood pressure, breast cancer screening per guidelines, lipid/glucose testing as indicated, and reassessment of symptoms and side effects. Bottom line recommendation Ask for FDA‑approved, bioidentical estradiol (prefer transdermal if clot risk) plus micronized progesterone (Prometrium) if you need progestogen; ask about Bijuva if you want a combined oral bioidentical option. Reserve compounded BHRT only for specific, justified cases and only from a well‑vetted compounding pharmacy with an explicit monitoring plan. If you want, tell me your age, symptoms, medical history (esp. clotting, breast cancer, smoking, cardiovascular disease), and whether you still have a uterus — I can give a more tailored suggestion and wording to bring to your clinician.

Mentioned in position 8 of 12

Short answer: Yes — it’s usually not “too late.” Many people start hormone replacement therapy (HRT) in their late 50s and get good relief of hot flashes, night sweats, vaginal dryness and improved sleep and quality of life. Whether it’s right for you depends on your health history, symptoms, and individual risks. What to know Benefits: HRT is the most effective treatment for menopause-related hot flashes and night sweats, helps vaginal dryness and sexual discomfort, and preserves bone density. Timing and risk: Starting HRT closer to menopause (generally within 10 years of your last period or under about age 60) tends to give the best balance of benefits vs cardiovascular risk. That said, people in their late 50s often still fall into this lower‑risk group and can safely take HRT if they’re otherwise healthy. Main risks to check: personal or strong family history of breast cancer, history of blood clots (deep vein thrombosis or pulmonary embolus), stroke, uncontrolled high blood pressure, active liver disease, or unusual uterine bleeding. Smoking and older age increase some risks. Formulation matters: transdermal estradiol (patch or gel) has lower risk of blood clots and stroke than oral estrogen. If you have a uterus, you also need progestogen to protect the endometrium (unless you have a hysterectomy). Local low‑dose vaginal estrogen is highly effective for vaginal symptoms and has minimal systemic exposure. Practical options (brand examples) Transdermal estrogen patches (preferred for older starters to reduce VTE risk): Climara, Vivelle‑Dot, Alora. Estradiol gels: Divigel, EstroGel. Oral estradiol or conjugated estrogens: Estrace (estradiol), Premarin (conjugated equine estrogens) — oral forms are effective but have higher VTE/stroke risk than transdermal. Progestogens: micronized progesterone (Prometrium) — often preferred for a more “physiologic” profile; medroxyprogesterone acetate (Provera) is another common option but has a different risk profile. A levonorgestrel IUD (Mirena) provides local progestin protection if you prefer that route. Combined SERM + estrogen (for some with uterus who want to avoid a progestin): Duavee (bazedoxifene + conjugated estrogens) — approved for hot flashes and bone protection in certain women. Vaginal/local estrogen for genital symptoms only: Estrace cream, Estring ring, Vagifem pessaries/tablets. What your clinician will likely do Review medical and family history (especially breast cancer and clotting history), medications, smoking status. Baseline checks: blood pressure, weight/BMI, current mammogram status, possibly fasting lipids and glucose if indicated. Discuss the lowest effective dose and plan for follow‑up (usually a check within 3 months, then annually). Reassess need and risks periodically. If you have specific conditions (prior breast cancer, prior clot, high stroke risk), HRT may be contraindicated and other treatments (antidepressants, gabapentin, nonhormonal vaginal therapies, or osteoporosis medications like bisphosphonates or denosumab) might be recommended. Next steps Book an appointment with your primary care doctor, gynecologist, or a menopause specialist and bring a brief list of your symptoms, medical history, family history (breast/clotting), medications, and last mammogram date. If you want, tell me a bit about your symptoms and health history and I can help draft questions to ask your clinician or explain likely options for you. References/resources North American Menopause Society (NAMS) and local health services (NHS, Endocrine Society) have patient guidance if you want to read more. Would you like help drafting questions to take to your doctor or want to tell me about your medical history so I can give more tailored info?

Mentioned in position 11 of 13